BlinkLab
@blink_lab
Digital Sensory Phenotyping for Autism and ADHD
You might like
BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics for neurodevelopmental conditions, is pleased to provide its activity report for the quarter ended September 30 2025, along with a financial and corporate update for the period.…
BlinkLab (ASX: BB1) has completed a US pilot study evaluating the smartphone-based Dx 1 diagnostic device for the assessment of behavioural and developmental concerns in children, including autism spectrum disorder and attention deficit hyperactivity disorder. Read more:…
BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to provide a recording from the recent Investor Webinar where Dr Henk-Jan Boele (BlinkLab’s Co-Founder and CEO) and Mr Brian Leedman (BlinkLab’s Chairman) provided an…
BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce the successful completion of its United States pilot study evaluating the Company’s smartphone-based digital diagnostic test autism spectrum disorder,…
Yesterday, BlinkLab (ASX:BB1) Chairman, Mr Brian Leedman, presented at Stocks On Location: On Track among a range of leaders from exciting ASX-listed companies across healthcare, finance, and resources. Mr Leedman provided an overview of BlinkLab’s smartphone-based diagnostic…
Mr Brian Leedman, Chairman of BlinkLab Limited (ASX:BB1), featured today as a speaker at Stocks On Location: On Track – hosted by the incredible team at The Capital Network and partnered with Foley Durham Executive Search & Board Advisory. As BlinkLab advances its AI-powered…
BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce that it has engaged The Vanderbilt Kennedy Center (VKC) in Nashville, Tennessee as the latest clinical research site for its ongoing FDA 510(k) diagnostic…
BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce it has engaged The University of Missouri Thompson Center for Autism & Neurodevelopment to serve as a clinical research site as part of its ongoing FDA…
BlinkLab Limited (ASX:BB1), a digital healthcare company developing AI-powered diagnostic tools, today announced that Cincinnati Children’s Medical Center and Seattle Children’s Research Institute have been engaged as additional clinical sites for the main study phase of its…
BlinkLab Limited (ASX:BB1) is pleased to provide a recording from the recent TechKnow Invest Roadshow, where Chairman Brian Leedman highlighted the company's latest activities. 📺 Watch video: buff.ly/Y6nayN $BB1 #awareness #autismspeaks
BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce it has engaged The University of Pennsylvania Perelman School of Medicine as its third clinical site for its ongoing FDA 510(k) diagnostic trial for the…
BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Register via buff.ly/xZ0EptZ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks @VEvents_RIU
BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Download the latest Investor presentation: buff.ly/QZ8wk11 Please email [email protected] to arrange a 1:1 meeting. $BB1.ax #awareness…
🔊 REMINDER: Brian Leedman presenting TODAY!
BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Register via buff.ly/xZ0EptZ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks @VEvents_RIU
Blinklab is pleased to be included in the recent @StockheadAU article "Morgans spotlights nine healthcare stocks with upcoming catalysts" Read more: buff.ly/Gf4FZa4 $BB1 #awareness #autismspeaks
BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Register via buff.ly/xZ0EptZ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks @VEvents_RIU
🔊 REMINDER: BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, presenting TODAY!
BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the 19th Bioshares Biotech Summit. Register via buff.ly/JTn1xJ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks
BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the 19th Bioshares Biotech Summit. Register via buff.ly/JTn1xJ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks
BlinkLab (ASX:BB1) is pleased to provide shareholders and investors with its activities report to accompany the Appendix 5B for the quarter ending 30 June 2025. Read more: buff.ly/thHQDY7 $BB1 #awareness #autismspeaks
United States Trends
- 1. Veterans Day 104K posts
- 2. Mainz Biomed N/A
- 3. United States Armed Forces N/A
- 4. Good Tuesday 32.6K posts
- 5. SoftBank 9,042 posts
- 6. #Talus_Labs N/A
- 7. Vets 14.8K posts
- 8. #MYNZ 1,468 posts
- 9. #tuesdayvibe 1,955 posts
- 10. Nasdaq 37.5K posts
- 11. Armistice Day 13.3K posts
- 12. Wike 14.8K posts
- 13. #ARMY 1,762 posts
- 14. Bond 64.3K posts
- 15. #Gratitude 1,594 posts
- 16. Antifa 122K posts
- 17. ORGANIZACIÓN POPULAR 2,764 posts
- 18. Taco Tuesday 12K posts
- 19. BNB Chain 48.7K posts
- 20. Fritz 8,040 posts
You might like
Something went wrong.
Something went wrong.